1. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia. 1988;8 (Suppl 7):1–96. [PubMed] [Google Scholar]
2. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders. Cephalalgia. 2004;24:1–160. [PubMed] [Google Scholar]
3. Trobe JD. Photophobia in anterior visual pathway disease. J Neuroophthalmol. 2002;22:1–2. [PubMed] [Google Scholar]
4. Webster’s New World Dictionary. Cleveland: The World Publishing Company; 1968. [Google Scholar]
5. Lebensohn J. The nature of photophobia. Arch Ophthalmol. 1934;12:380–383. [Google Scholar]
6. Cummings JL, Gittinger JW., Jr Central dazzle. A thalamic syndrome? Arch Neurol. 1981;38:372–374. [PubMed] [Google Scholar]
7. Loewenfeld I. The Pupil: Anatomy, Physiology, and Clinical Applications. Detroit: Wayne State University Press; 1993. The “dazzling” syndrome; p. 1200. [Google Scholar]
8. Ohba N, Ohba A. Nyctalopia and hemeralopia: the current usage trend in the literature. Br J Ophthalmol. 2006;90:1548–1549. [PMC free article] [PubMed] [Google Scholar]
9. Fine PG, Digre KB. A controlled trial of regional sympatholysis in the treatment of photo-oculodynia syndrome. J Neuroophthalmol. 1995;15:90–94. [PubMed] [Google Scholar]
10. Burstein R, Cutrer MF, Yarnitsky D. The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain. 2000;123 ( Pt 8):1703–1709. [PubMed] [Google Scholar]
11. Mathew NT, Kailasam J, Seifert T. Clinical recognition of allodynia in migraine. Neurology. 2004;63:848–852. [PubMed] [Google Scholar]
12. Buchanan T, Digre K, Warner JE, Katz BJ. A review of the symptom of photophobia in an eye clinic. Neurology. 2009;72:A 184. [Google Scholar]
13. Pflugfelder SC. Tear Dysfunction and the Cornea: LXVIII Edward Jackson Memorial Lecture. Am J Ophthalmol. 2011;152:900–909. e901. [PMC free article] [PubMed] [Google Scholar]
14. Benitez-Del-Castillo JM, Acosta MC, Wassfi MA, Diaz-Valle D, Gegundez JA, Fernandez C, Garcia-Sanchez J. Relation between corneal innervation with confocal microscopy and corneal sensitivity with noncontact esthesiometry in patients with dry eye. Invest Ophthalmol Vis Sci. 2007;48:173–181. [PubMed] [Google Scholar]
15. Karmel M. [Accessed November 18, 2011];Addressing the pain of corneal neuropathy [online] Available at: http://www.aao.org/publications/eyenet/201007/upload/29_CUcornea_FF_copy.pdf.
16. Prokofyeva E, Troeger E, Wilke R, Zrenner E. Early visual symptom patterns in inherited retinal dystrophies. Ophthalmologica. 2011;226:151–156. [PubMed] [Google Scholar]
17. Zervas JP, Smith JL. Neuro-ophthalmic presentation of cone dysfunction syndromes in the adult. J Clin Neuroophthalmol. 1987;7:202–218. [PubMed] [Google Scholar]
18. Simunovic MP, Moore AT. The cone dystrophies. Eye (Lond) 1998;12 ( Pt 3b):553–565. [PubMed] [Google Scholar]
19. Russell-Eggitt IM, Clayton PT, Coffey R, Kriss A, Taylor DS, Taylor JF. Alstrom syndrome. Report of 22 cases and literature review. Ophthalmology. 1998;105:1274–1280. [PubMed] [Google Scholar]
20. Lamonte M, Silberstein SD, Marcelis JF. Headache associated with aseptic meningitis. Headache. 1995;35:520–526. [PubMed] [Google Scholar]
21. Welty TE, Horner TG. Pathophysiology and treatment of subarachnoid hemorrhage. Clin Pharm. 1990;9:35–39. [PubMed] [Google Scholar]
22. Kawasaki A, Purvin VA. Photophobia as the presenting visual symptom of chiasmal compression. J Neuroophthalmol. 2002;22:3–8. [PubMed] [Google Scholar]
23. Fricke B, Andres KH, Von During M. Nerve fibers innervating the cranial and spinal meninges: morphology of nerve fiber terminals and their structural integration. Microsc Res Tech. 2001;53:96–105. [PubMed] [Google Scholar]
24. Choi JY, Oh K, Kim BJ, Chung CS, Koh SB, Park KW. Usefulness of a photophobia questionnaire in patients with migraine. Cephalalgia. 2009;29:953–959. [PubMed] [Google Scholar]
25. Lipton RB, Dodick D, Sadovsky R, Kolodner K, Endicott J, Hettiarachchi J, Harrison W. A self-administered screener for migraine in primary care: The ID Migraine validation study. Neurology. 2003;61:375–382. [PubMed] [Google Scholar]
26. Drummond PD, Woodhouse A. Painful stimulation of the forehead increases photophobia in migraine sufferers. Cephalalgia. 1993;13:321–324. [PubMed] [Google Scholar]
27. Vanagaite J, Pareja JA, Storen O, White LR, Sand T, Stovner LJ. Light-induced discomfort and pain in migraine. Cephalalgia. 1997;17:733–741. [PubMed] [Google Scholar]
28. Vincent AJ, Spierings EL, Messinger HB. A controlled study of visual symptoms and eye strain factors in chronic headache. Headache. 1989;29:523–527. [PubMed] [Google Scholar]
29. Good PA, Taylor RH, Mortimer MJ. The use of tinted glasses in childhood migraine. Headache. 1991;31:533–536. [PubMed] [Google Scholar]
30. Chronicle EP, Mulleners WM. Visual system dysfunction in migraine: a review of clinical and psychophysical findings. Cephalalgia. 1996;16:525–535. discussion 523. [PubMed] [Google Scholar]
31. Drummond PD. A quantitative assessment of photophobia in migraine and tension headache. Headache. 1986;26:465–469. [PubMed] [Google Scholar]
32. Irimia P, Cittadini E, Paemeleire K, Cohen AS, Goadsby PJ. Unilateral photophobia or phonophobia in migraine compared with trigeminal autonomic cephalalgias. Cephalalgia. 2008;28:626–630. [PubMed] [Google Scholar]
33. Cittadini E, Goadsby PJ. Hemicrania continua: a clinical study of 39 patients with diagnostic implications. Brain. 2010;133:1973–1986. [PubMed] [Google Scholar]
34. Waddell PA, Gronwall DM. Sensitivity to light and sound following minor head injury. Acta Neurol Scand. 1984;69:270–276. [PubMed] [Google Scholar]
35. Vos PE, Battistin L, Birbamer G, Gerstenbrand F, Potapov A, Prevec T, Stepan ChA, Traubner P, Twijnstra A, Vecsei L, von Wild K. EFNS guideline on mild traumatic brain injury: report of an EFNS task force. Eur J Neurol. 2002;9:207–219. [PubMed] [Google Scholar]
36. Bohnen N, Twijnstra A, Wijnen G, Jolles J. Tolerance for light and sound of patients with persistent post-concussional symptoms 6 months after mild head injury. J Neurol. 1991;238:443–446. [PubMed] [Google Scholar]
37. Nampiaparampil DE. Prevalence of chronic pain after traumatic brain injury: a systematic review. JAMA. 2008;300:711–719. [PubMed] [Google Scholar]
38. Hoge CW, McGurk D, Thomas JL, Cox AL, Engel CC, Castro CA. Mild traumatic brain injury in U.S. Soldiers returning from Iraq. N Engl J Med. 2008;358:453–463. [PubMed] [Google Scholar]
39. Ruff RL, Ruff SS, Wang XF. Headaches among Operation Iraqi Freedom/Operation Enduring Freedom veterans with mild traumatic brain injury associated with exposures to explosions. J Rehabil Res Dev. 2008;45:941–952. [PubMed] [Google Scholar]
40. Neely ET, Midgette LA, Scher AI. Clinical review and epidemiology of headache disorders in US service members: with emphasis on post-traumatic headache. Headache. 2009;49:1089–1096. [PubMed] [Google Scholar]
41. Berardelli A, Rothwell JC, Day BL, Marsden CD. Pathophysiology of blepharospasm and oromandibular dystonia. Brain. 1985;108 ( Pt 3):593–608. [PubMed] [Google Scholar]
42. Anderson RL, Patel BC, Holds JB, Jordan DR. Blepharospasm: past, present, and future. Ophthal Plast Reconstr Surg. 1998;14:305–317. [PubMed] [Google Scholar]
43. Judd R, Digre KB, Warner JE, Schulman S, Katz BJ. Shedding light on blepharospasm: a patient-researcher partnership approach to assessment of photophobia and impact on activities of daily living. Neuro-Ophthalmology. 2007;31:49–54. [Google Scholar]
44. Adams WH, Digre KB, Patel BC, Anderson RL, Warner JE, Katz BJ. The evaluation of light sensitivity in benign essential blepharospasm. Am J Ophthalmol. 2006;142:82–87. [PubMed] [Google Scholar]
45. Cooper AD, Josephs KA. Photophobia, visual hallucinations, and REM sleep behavior disorder in progressive supranuclear palsy and corticobasal degeneration: a prospective study. Parkinsonism Relat Disord. 2009;15:59–61. [PubMed] [Google Scholar]
46. Hills W, Warner JE, Katz BJ, Chelune G, Foster N, Steffens J, Thulin P, Chin S, Digre K. American Academy of Neurology. Chicago: 2008. Neuro-ophthalmic findings that may reliably differentiate progressive supranuclear palsy and Parkinson’s disease. [Google Scholar]
47. Kellner M, Wiedemann K, Zihl J. Illumination perception in photophobic patients suffering from panic disorder with agoraphobia. Acta Psychiatr Scand. 1997;96:72–74. [PubMed] [Google Scholar]
48. Shirani A, St Louis EK. Illuminating rationale and uses for light therapy. J Clin Sleep Med. 2009;5:155–163. [PMC free article] [PubMed] [Google Scholar]
49. Gerbaldo H. Depression and photophobic behavior. Am J Psychiatry. 1988;145:1479–1480. [PubMed] [Google Scholar]
50. Gerbaldo H, Thaker G. Photophilic and photophobic behaviour in patients with schizophrenia and depression. Can J Psychiatry. 1991;36:677–679. [PubMed] [Google Scholar]
51. Gallin PF, Terman M, Reme CE, Rafferty B, Terman JS, Burde RM. Ophthalmologic examination of patients with seasonal affective disorder, before and after bright light therapy. Am J Ophthalmol. 1995;119:202–210. [PubMed] [Google Scholar]
52. Bossini L, fa*giolini A, Valdagno M, Padula L, Hofkens T, Castrogiovanni P. Photosensitivity in panic disorder. Depress Anxiety. 2009;26:E34–36. [PubMed] [Google Scholar]
53. Bengtzen R, Woodward M, Lynn MJ, Newman NJ, Biousse V. The “sunglasses sign” predicts nonorganic visual loss in neuro-ophthalmologic practice. Neurology. 2008;70:218–221. [PubMed] [Google Scholar]
54. Schutz JS, Mavrakanas NA. The value of the ophthalmological independent medical examination: analysis of 344 cases. Br J Ophthalmol. 2009;93:1371–1375. [PubMed] [Google Scholar]
55. Weller M, Wiedemann P. Hysterical symptoms in ophthalmology. Doc Ophthalmol. 1989;73:1–33. [PubMed] [Google Scholar]
56. Burton H. Somatic sensation from the eye. In: Hart WM, editor. Adler’s Physiology of the Eye. St. Louis: Mosby Year Book; 1992. pp. 71–100. [Google Scholar]
57. Last R. Eugene Wolff’s Anatomy of the Eye and Orbit. 5. Philadelphia: W.B. Saunders; 1961. [Google Scholar]
58. Edvinsson L, Uddman R. Neurobiology in primary headaches. Brain Res Brain Res Rev. 2005;48:438–456. [PubMed] [Google Scholar]
59. Goadsby PJ, Charbit AR, Andreou AP, Akerman S, Holland PR. Neurobiology of migraine. Neuroscience. 2009;161:327–341. [PubMed] [Google Scholar]
60. Goadsby PJ. Pathophysiology of migraine. Neurol Clin. 2009;27:335–360. [PubMed] [Google Scholar]
61. Akerman S, Holland PR, Goadsby PJ. Diencephalic and brainstem mechanisms in migraine. Nat Rev Neurosci. 2011;12:570–584. [PubMed] [Google Scholar]
62. Marfurt CF. Sympathetic innervation of the rat cornea as demonstrated by the retrograde and anterograde transport of horseradish peroxidase-wheat germ agglutinin. J Comp Neurol. 1988;268:147–160. [PubMed] [Google Scholar]
63. Davis L, Pollock L. The rôle of the sympathetic nervous system in the production of pain in the head. Arch Neurol Psychiatry. 1932;27:282–293. [Google Scholar]
64. McCann JD, Gauthier M, Morschbacher R, Goldberg RA, Anderson RL, Fine PG, Digre KB. A novel mechanism for benign essential blepharospasm. Ophthal Plast Reconstr Surg. 1999;15:384–389. [PubMed] [Google Scholar]
65. Esteban A. A neurophysiological approach to brainstem reflexes. Blink reflex. Neurophysiol Clin. 1999;29:7–38. [PubMed] [Google Scholar]
66. Yates SK, Brown WF. Light-stimulus-evoked blink reflex: methods, normal values, relation to other blink reflexes, and observations in multiple sclerosis. Neurology. 1981;31:272–281. [PubMed] [Google Scholar]
67. Bologna M, Agostino R, Gregori B, Belvisi D, Ottaviani D, Colosimo C, Fabbrini G, Berardelli A. Voluntary, spontaneous and reflex blinking in patients with clinically probable progressive supranuclear palsy. Brain. 2009;132:502–510. [PubMed] [Google Scholar]
68. Pearce JM. Observations on the blink reflex. Eur Neurol. 2008;59:221–223. [PubMed] [Google Scholar]
69. Aramideh M, Ongerboer de Visser BW. Brainstem reflexes: electrodiagnostic techniques, physiology, normative data, and clinical applications. Muscle Nerve. 2002;26:14–30. [PubMed] [Google Scholar]
70. Blackburn MK, Lamb RD, Digre KB, Smith AG, Warner JE, McClane RW, Nandedkar SD, Langeberg WJ, Holubkov R, Katz BJ. FL-41 tint improves blink frequency, light sensitivity, and functional limitations in patients with benign essential blepharospasm. Ophthalmology. 2009;116:997–1001. [PMC free article] [PubMed] [Google Scholar]
71. Siegwart K. Zur Frage nach dem Vorkommen and dem Wesen des Blednungsschmerzes. Schweizmed Wchschr. 1920;50:1165. [Google Scholar]
72. Zaidi FH, Hull JT, Peirson SN, Wulff K, Aeschbach D, Gosley JJ, Brainard GS, Gregory-Evans K, Rizzo J, Czeisler CA, Foster RG, Lockley SW. Short-wavelength light sensitivity of circadian, pupillary, and visual awareness in humans lacking an outer retina. Curr Biol. 2007;17:2122–2128. [PMC free article] [PubMed] [Google Scholar]
73. Noseda R, Burstein R. Advances in understanding the mechanisms of migraine-type photophobia. Curr Opin Neurol. 2011;24:197–202. [PMC free article] [PubMed] [Google Scholar]
74. Amini A, Digre K, Couldwell WT. Photophobia in a blind patient: An alternate visual pathway. Case report. J Neurosurg. 2006;105:765–768. [PubMed] [Google Scholar]
75. Guler AD, Ecker JL, Lall GS, Haq S, Altimus CM, Lido HW, Barnard AR, Cahill H, Badea TC, Zhao H, Hankins MW, Berson DM, Lucas RJ, Yau KW, Haltar S. Melanopsin cells are the principal conduits for rod-cone input to non-image-forming vision. Nature. 2008;453:102–105. [PMC free article] [PubMed] [Google Scholar]
76. Wilhelm H. The pupil. Curr Opin Neurol. 2008;21:36–42. [PubMed] [Google Scholar]
77. Kardon R, Anderson SC, Damarjian TG, Grace EM, Stone E, Kawasaki A. Chromatic pupil responses: preferential activation of the melanopsin-mediated versus outer photoreceptor-mediated pupil light reflex. Ophthalmology. 2009;116:1564–1573. [PubMed] [Google Scholar]
78. Kawasaki A, Kardon RH. Intrinsically photosensitive retinal ganglion cells. J Neuroophthalmol. 2007;27:195–204. [PubMed] [Google Scholar]
79. Berson DM, Dunn FA, Takao M. Phototransduction by retinal ganglion cells that set the circadian clock. Science. 2002;295:1070–1073. [PubMed] [Google Scholar]
80. Hattar S, Liao HW, Takao M, Berson DM, Yau KW. Melanopsin-containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity. Science. 2002;295:1065–1070. [PMC free article] [PubMed] [Google Scholar]
81. Do MT, Yau KW. Intrinsically photosensitive retinal ganglion cells. Physiol Rev. 2010;90:1547–1581. [PMC free article] [PubMed] [Google Scholar]
82. Chen SK, Badea TC, Hattar S. Photoentrainment and pupillary light reflex are mediated by distinct populations of ipRGCs. Nature. 2011;476:92–95. [PMC free article] [PubMed] [Google Scholar]
83. Schmidt TM, Chen SK, Hattar S. Intrinsically photosensitive retinal ganglion cells: many subtypes, diverse functions. Trends Neurosci. 2011;34:572–580. [PMC free article] [PubMed] [Google Scholar]
84. Xue T, Do MT, Riccio A, Jiang Z, Hsieh J, Wang HC, Merbs SL, Welsbie DS, Yoshioka T, Weissgerber P, STolz S, Flockerzi V, Friechel M, Simon MI, Clapham DE, Yau KW. Melanopsin signalling in mammalian iris and retina. Nature. 2011;479:67–73. [PMC free article] [PubMed] [Google Scholar]
85. Okamoto K, Thompson R, Tashiro A, Chang Z, Bereiter DA. Bright light produces Fos-positive neurons in caudal trigeminal brainstem. Neuroscience. 2009;160:858–864. [PubMed] [Google Scholar]
86. Noseda R, Constandil L, Bourgeais L, Chalus M, Villanueva L. Changes of meningeal excitability mediated by corticotrigeminal networks: a link for the endogenous modulation of migraine pain. J Neurosci. 2010;30:14420–14429. [PMC free article] [PubMed] [Google Scholar]
87. Hirata A, Aguilar J, Castro-Alamancos MA. Noradrenergic activation amplifies bottom-up and top-down signal-to-noise ratios in sensory thalamus. J Neurosci. 2006;26:4426–4436. [PMC free article] [PubMed] [Google Scholar]
88. Llinas RR, Steriade M. Bursting of thalamic neurons and states of vigilance. J Neurophysiol. 2006;95:3297–3308. [PubMed] [Google Scholar]
89. Steriade M, McCormick DA, Sejnowski TJ. Thalamocortical oscillations in the sleeping and aroused brain. Science. 1993;262:679–685. [PubMed] [Google Scholar]
90. Nicolelis MA, Fanselow EE. Thalamocortical [correction of Thalamcortical] optimization of tactile processing according to behavioral state. Nat Neurosci. 2002;5:517–523. [PubMed] [Google Scholar]
91. Dolgonos S, Ayyala H, Evinger C. Light-induced trigeminal sensitization without central visual pathways: another mechanism for photophobia. Invest Ophthalmol Vis Sci. 2011;52:7852–7858. [PMC free article] [PubMed] [Google Scholar]
92. Custer PL, Reistad CE. Enucleation of blind, painful eyes. Ophthal Plast Reconstr Surg. 2000;16:326–329. [PubMed] [Google Scholar]
93. Olesen J, Diener HC, Husstedt IW, Goadsby PJ, Hall D, Meier U, Pollentier S, Lesko LM. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med. 2004;350:1104–1110. [PubMed] [Google Scholar]
94. Ho TW, Ferrari MD, Dodick DW, Galet V, Kost J, Fan X, Leibensperger H, Froman S, Assaid C, Lines C, Koppen H, Winner PK. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial. Lancet. 2008;372:2115–2123. [PubMed] [Google Scholar]
95. Russo AF, Kuburas A, Kaiser EA, Raddant AC, Recober A. A Potential Preclinical Migraine Model: CGRP-Sensitized Mice. Mol Cell Pharmacol. 2009;1:264–270. [PMC free article] [PubMed] [Google Scholar]
96. Sprenger T, Goadsby PJ. Migraine pathogenesis and state of pharmacological treatment options. BMC Med. 2009;7:71. [PMC free article] [PubMed] [Google Scholar]
97. Recober A, Kaiser EA, Kuburas A, Russo AF. Induction of multiple photophobic behaviors in a transgenic mouse sensitized to CGRP. Neuropharmacology. 2010;58:156–165. [PMC free article] [PubMed] [Google Scholar]
98. Recober A, Kuburas A, Zhang Z, Wemmie JA, Anderson MG, Russo AF. Role of calcitonin gene-related peptide in light-aversive behavior: implications for migraine. J Neurosci. 2009;29:8798–8804. [PMC free article] [PubMed] [Google Scholar]
99. Vanagaite Vingen J, Stovner LJ. Photophobia and phonophobia in tension-type and cervicogenic headache. Cephalalgia. 1998;18:313–318. [PubMed] [Google Scholar]
100. Wirtschafter JD, Bourassa CM, Dow RS. The quantitative study of photophobia. Trans Am Neurol Assoc. 1963;88:291–293. [PubMed] [Google Scholar]
101. Marks L. Brightness and equivalent intensity of intrinsic light. Vision Res. 1973;13:371–382. [PubMed] [Google Scholar]
102. Lamb TD, Pugh EN., Jr Dark adaptation and the retinoid cycle of vision. Prog Retin Eye Res. 2004;23:307–380. [PubMed] [Google Scholar]
103. Main A, Vlachonikolis I, Dowson A. The wavelength of light causing photophobia in migraine and tension-type headache between attacks. Headache. 2000;40:194–199. [PubMed] [Google Scholar]
104. Brainard GC, Sliney D, Hanifin JP, Glickman G, Byrne B, Greeson JM, Jassen S, Gerna E, Rollag MD. Sensitivity of the human circadian system to short-wavelength (420-nm) light. J Biol Rhythms. 2008;23:379–386. [PubMed] [Google Scholar]
105. Kowacs PA, Piovesan EJ, Werneck LC, Tatsui CE, Lange MC, Ribas LC, da Silva HP. Influence of intense light stimulation on trigeminal and cervical pain perception thresholds. Cephalalgia. 2001;21:184–188. [PubMed] [Google Scholar]
106. Moulton EA, Becerra L, Borsook D. An fMRI case report of photophobia: activation of the trigeminal nociceptive pathway. Pain. 2009;145:358–363. [PMC free article] [PubMed] [Google Scholar]
107. Legrain V, Iannetti GD, Plaghki L, Mouraux A. The pain matrix reloaded: a salience detection system for the body. Prog Neurobiol. 2011;93:111–124. [PubMed] [Google Scholar]
108. Malecaze FJ, Boulanouar KA, Demonet JF, Guell JL, Imbert MA. Abnormal activation in the visual cortex after corneal refractive surgery for myopia: demonstration by functional magnetic resonance imaging. Ophthalmology. 2001;108:2213–2218. [PubMed] [Google Scholar]
109. Emoto H, Suzuki Y, Wakakura M, Horie C, Kiyosawa M, Mochizuki M, Kawasaki K, Oda K, Ishiwata K, Ishii K. Photophobia in essential blepharospasm--a positron emission tomographic study. Mov Disord. 2010;25:433–439. [PubMed] [Google Scholar]
110. Coppola G, Pierelli F, Schoenen J. Is the cerebral cortex hyperexcitable or hyperresponsive in migraine? Cephalalgia. 2007;27:1427–1439. [PubMed] [Google Scholar]
111. Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol. 1981;9:344–352. [PubMed] [Google Scholar]
112. Hadjikhani N, Sanchez Del Rio M, Wu O, Schwartz D, Bakker D, Fischi B, Kwang KK, Cotren FM, Rosen BR, Tootell RB, Sorensen AG, Moskowitz MA. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A. 2001;98:4687–4692. [PMC free article] [PubMed] [Google Scholar]
113. Denuelle M, Boulloche N, Payoux P, Fabre N, Trotter Y, Geraud G. A PET study of photophobia during spontaneous migraine attacks. Neurology. 2011;76:213–218. [PubMed] [Google Scholar]
114. Boulloche N, Denuelle M, Payoux P, Fabre N, Trotter Y, Geraud G. Photophobia in migraine: an interictal PET study of cortical hyperexcitability and its modulation by pain. J Neurol Neurosurg Psychiatry. 2010;81:978–984. [PubMed] [Google Scholar]
115. Brennan KC. Turn down the lights!: an irritable occipital cortex in migraine without aura. Neurology. 2011;76:206–207. [PubMed] [Google Scholar]
116. Martin H, Del Rio MS, de Silanes CL, Alvarez-Linera J, Hernandez JA, Pareja JA. Photoreactivity of the Occipital Cortex Measured by Functional Magnetic Resonance Imaging-Blood Oxygenation Level Dependent in Migraine Patients and Healthy Volunteers: Pathophysiological Implications. Headache. 2011;51:1520–1528. [PubMed] [Google Scholar]
117. Llop S, Frandsen F, Katz BJ, Warner JE, Digre K. Depression and anxiety in migraine patients with and without chronic photophobia. Headache. 2010;50:S45. [PMC free article] [PubMed] [Google Scholar]
118. Bruce BB, Newman NJ. Functional visual loss. Neurol Clin. 2010;28:789–802. [PMC free article] [PubMed] [Google Scholar]
119. Howard RJ, Valori RM. Hospital patients who wear tinted spectacles--physical sign of psychoneurosis: a controlled study. J R Soc Med. 1989;82:606–608. [PMC free article] [PubMed] [Google Scholar]
120. Marshall JD, Paisey RB, Carey C, Macdermott S. Alstrom Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews [Internet] Seattle: University of Washington; 1993–2003. Feb 07, [updated 2010 Jun 08] [Google Scholar]
121. Rajak SN, Currie AD, Dubois VJ, Morris M, Vickers S. Tinted contact lenses as an alternative management for photophobia in stationary cone dystrophies in children. J AAPOS. 2006;10:336–339. [PubMed] [Google Scholar]
122. Michaelides M, Hunt DM, Moore AT. The cone dysfunction syndromes. Br J Ophthalmol. 2004;88:291–297. [PMC free article] [PubMed] [Google Scholar]
123. Young RS, Krefman RA, Fishman GA. Visual improvements with red-tinted glasses in a patient with cone dystrophy. Arch Ophthalmol. 1982;100:268–271. [PubMed] [Google Scholar]
124. Park WL, Sunness JS. Red contact lenses for alleviation of photophobia in patients with cone disorders. Am J Ophthalmol. 2004;137:774–775. [PubMed] [Google Scholar]
125. Karanovic O, Thabet M, Wilson HR, Wilkinson F. Detection and discrimination of flicker contrast in migraine. Cephalalgia. 2011;31:723–736. [PMC free article] [PubMed] [Google Scholar]
126. Huang J, Zong X, Wilkins A, Jenkins B, Bozoki A, Cao Y. fMRI evidence that precision ophthalmic tints reduce cortical hyperactivation in migraine. Cephalalgia. 2011;31:925–936. [PMC free article] [PubMed] [Google Scholar]
127. Hallett M, Evinger C, Jankovic J, Stacy M. Update on blepharospasm: report from the BEBRF International Workshop. Neurology. 2008;71:1275–1282. [PMC free article] [PubMed] [Google Scholar]
128. McDonald MB, Wyse TB, Borodkin MJ, Ocmand A, Shoelson B, Thompson H. Comparison of the effectiveness of 4 anti-inflammatory drops in relieving photophobia after pupil dilation. J Cataract Refract Surg. 1999;25:405–410. [PubMed] [Google Scholar]
129. Brierley L. Effect of lidocaine on photophobia. J Cataract Refract Surg. 1999;25:1177. [PubMed] [Google Scholar]
130. Lebensohn JE. Photophobia: mechanism and implications. Am J Ophthalmol. 1951;34:1294–1300. [PubMed] [Google Scholar]
131. Spencer BR, Jr, Digre KB. Treatments for neuro-ophthalmologic conditions. Neurol Clin. 2010;28:1005–1035. [PubMed] [Google Scholar]
132. Hoyt W. Walsh and Hoyt’s Neuro-Ophthalmology. 3. Philadelphia: Lippincott Williams and Wilkens; 1969. [Google Scholar]
133. Freeman MD, Nystrom A, Centeno C. Chronic whiplash and central sensitization; an evaluation of the role of a myofascial trigger points in pain modulation. J Brachial Plex Peripher Nerve Inj. 2009;4:2. [PMC free article] [PubMed] [Google Scholar]
134. Shoari M, Katz BJ. Treatment of the photo-oculodynia syndrome with Botulinum toxin A. Neuro-Ophthalmology. 2007;31:105–110. [Google Scholar]
135. Diener HC, Dodick DW, Aurora SK, Turkell CC, DeGryse RE, Lipton RB, Silberstein SD, Brin MF. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia. 2010;30:804–814. [PubMed] [Google Scholar]
136. Magitot A. Photophobie. Ann D’ocul. 1937;174:917. [Google Scholar]
137. Tugal-Tutkun I, Araz B, Taskapili M, Akora YA, Yalniz-Alkkaya Z, Berkeu N, Emie S, Gezer A. Bilateral acute depigmentation of the iris: report of 26 new cases and four-year follow-up of two patients. Ophthalmology. 2009;116:1552–1557. 1557, e1551. [PubMed] [Google Scholar]
138. Soeters MR, van Zeijl CJ, Boelen A, Kloos R, Saeed P, Vriesendrop TM, Mourits MP. Optimal management of Graves orbitopathy: a multidisciplinary approach. Neth J Med. 2011;69:302–308. [PubMed] [Google Scholar]
139. Enkvetchakul O, Thanathanee O, Rangsin R, Lekhanont K, Suwan-Apichon O. A randomized controlled trial of intralesional bevacizumab injection on primary pterygium: preliminary results. Cornea. 2011;30:1213–1218. [PubMed] [Google Scholar]
140. van der Veen RL, Fuijkschot J, Willemsen MA, Cruysberg JR, Berendschot TT, Theelen T. Patients with Sjogren-Larsson syndrome lack macular pigment. Ophthalmology. 2010;117:966–971. [PubMed] [Google Scholar]
141. Kaur H, Uy C, Kelly J, Moses AM. Orbital inflammatory disease in a patient treated with zoledronate. Endocr Pract. 2011;17:e101–103. [PubMed] [Google Scholar]
142. Alshami M, Bawazir MA, Atwan AA. Photoletter to the editor: A new variant of ichthyosis follicularis with alopecia and photophobia (IFAP) syndrome with coexisting psoriasiform lesions and palmoplantar keratoderma. IFAP-PPK syndrome? J Dermatol Case Rep. 2011;5:14–16. [PMC free article] [PubMed] [Google Scholar]
143. Megarbane H, Megarbane A. Ichthyosis follicularis, alopecia, and photophobia (IFAP) syndrome. Orphanet J Rare Dis. 2011;6:29. [PMC free article] [PubMed] [Google Scholar]
144. Carey J. Trisomy 18 and Trisomy 13 syndromes. In: Cassidy S, Allanson J, editors. Management of Genetic Syndromes. 3. Hoboken: Wiley-Blackwell; 2010. pp. 807–825. [Google Scholar]
145. Yu HH, Yang TM, Shan YS, Lin PW. Zinc deficiency in patients undergoing pancreatoduodenectomy for periampullary tumors is associated with pancreatic exocrine insufficiency. World J Surg. 2011;35:2110–2117. [PubMed] [Google Scholar]
